Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Is Ageless a Fantasy? The Swiss Brand Is Turning Longevity Into a Lifestyle


News provided by

Paremina, Inc.

Feb 01, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Once a subject of sci‑fi fantasy, the idea of slowing biological aging is rapidly entering the mainstream. Swiss longevity pioneer Paremina is at the forefront of this shift with Ageless Cell, a premium supplement positioned not just as a product, but as a gateway to an ageless lifestyle.

BOSTON, Feb. 1, 2026 /PRNewswire-PRWeb/ -- Once a subject of sci‑fi fantasy, the idea of slowing biological aging is rapidly entering the mainstream. Swiss longevity pioneer Paremina is at the forefront of this shift with Ageless Cell, a premium supplement positioned not just as a product, but as a gateway to an ageless lifestyle.

Where Nutraceuticals Meets Longevity Science

Emerging research in Geroscience, one of the disciplines of longevity study that links aging biology to disease—shows that prolonging healthspan requires more than surface‑level fixes. It means targeting the hallmarks of aging to preserve cellular integrity.

Ageless Cell's formula exemplifies this approach. Its core innovation, Epicell™, combines well‑known longevity molecules with three botanical stars: Monarda diydma (scarlet beebalm), Grape Seed and BlueBerry. In a randomized, placebo‑controlled clinical trial with 81 participants aged 45–65, the control group experienced an increase in biological age of just 0.1 years over 12 weeks versus 2.0 years in the placebo group. Researchers assessed biological age using telomere length and DNA methylation clocks; the intervention group also reported improved sleep and quality‑of‑life scores captured by wearable tech.

Laboratory studies complement these findings. Human fibroblasts treated with Monarda diydma extract showed significantly slower telomere shortening by nearly 50% (p = 0.0091) and reduced cellular DNAmAge up to 12 years old and cellular senescence by up to 80%. In vascular cell models, the extract decreased pro‑inflammatory proteins and oxidative stress while improving endothelial permeability. Together, these results suggest that Epicell™ helps stabilize biological age by protecting DNA, telomeres and the vascular system.

Epicell™ layers this botanical with nicotinamide riboside (NR)—a precursor to NAD⁺ that has been shown in human trials to boost NAD⁺ levels by 2.6‑ to 3.1‑fold after 5–10 weeks—alongside L‑ergothioneine and spermidine, compounds implicated in antioxidation, mitochondrial health and autophagy. The result is a synergistic formula that addresses aging at 12 high-recognized biological hallmarks all at once.

Wellness as the New Status Symbol

Behind the science lies a booming business. The U.S. longevity and general wellness supplements market was valued at $6.35 billion in 2025, and the global wellness economy reached $6.3 trillion in 2023. High‑net‑worth consumers are increasingly shifting their discretionary spend from conspicuous goods to healthspan‑enhancing experiences and products. Ageless Cell's distribution through select boutiques and longevity clinics in Europe, North America and Asia reflects this trend, tapping into a clientele that demands efficacy, exclusivity and sophistication.

Swiss Precision Meets Aspirational Living

Paremina positions itself at the intersection of scientific rigor and luxury wellness. The company sources and formulates its ingredients in Switzerland under pharmaceutical‑grade standards. According to Emilia Loewe, Head of Innovation, "Chronological age should not limit our capacity for life." Her message underscores a broader ethos: longevity isn't about defying time—it's about enhancing the quality of time through evidence‑based interventions.

Ageless Lifestyle, A Tasteful Approach to Aging

Ageless Cell isn't marketed as a miracle cure; rather, it's an invitation to cultivate vitality through mindful choices, high‑quality nutrition and a respect for science. Its supporters are investing in the ability to ski with their grandchildren, complete marathons in their sixties or simply feel sharp and energetic well into later decades.

In a market where the line between hype and health can blur, Paremina's Ageless Cell stands out by combining robust geroscience with refined branding. For those seeking to make longevity their next luxury pursuit, it offers a compelling blend of science, style and substance.

Media Contact

Cathy Wu, Paremina, Inc., 1 3074014012, [email protected], Paremina.com

SOURCE Paremina, Inc.

Modal title

The capsules are featured with Epicell™, naturally-derived longevity complex
The capsules are featured with Epicell™, naturally-derived longevity complex
The capsules are featured with Epicell™, naturally-derived longevity complex

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.